title: Regression of rubeosis in the fellow eye after intravitreal ranibizumab injection.
authors.affiliation: Department of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. julia.lueke@uk-sh.de
authors.forename: Julia
authors.initials: J
authors.lastname: Lüke
authors.forename: Khaled
authors.initials: K
authors.lastname: Nassar
authors.forename: Salvatore
authors.initials: S
authors.lastname: Grisanti
authors.forename: Matthias
authors.initials: M
authors.lastname: Lüke
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000150:complications*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D007498:Iris / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D000069579:Ranibizumab; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab